Canada markets closed

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0750+0.0150 (+1.42%)
At close: 04:00PM EDT
1.0900 +0.01 (+1.40%)
After hours: 07:36PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts4545
Avg. Estimate-0.1-0.06-0.28-0.42
Low Estimate-0.17-0.14-0.55-0.7
High Estimate-0.03-0.01-0.06-0.06
Year Ago EPS0.01-0.12-0.54-0.28
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts6767
Avg. Estimate10.73M25.91M75.01M56.04M
Low EstimateN/A4.4M22.2M21.5M
High Estimate45M38M137.3M90.7M
Year Ago Sales47.6M5.13M60.28M75.01M
Sales Growth (year/est)-77.50%405.10%24.40%-25.30%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.14-0.13-0.12-0.1
EPS Actual0.01-0.12-0.2-0.24
Difference0.150.01-0.08-0.14
Surprise %107.10%7.70%-66.70%-140.00%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.1-0.06-0.28-0.42
7 Days Ago-0.1-0.06-0.28-0.42
30 Days Ago-0.1-0.06-0.27-0.37
60 Days Ago-0.14-0.14-0.49-0.61
90 Days Ago-0.14-0.14-0.49-0.61
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesADAPIndustrySector(s)S&P 500
Current Qtr.-1,100.00%N/AN/AN/A
Next Qtr.50.00%N/AN/AN/A
Current Year48.10%N/AN/AN/A
Next Year-50.00%N/AN/AN/A
Next 5 Years (per annum)1.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A